PEBP1 and melanoma: On the other hand, changes in the levels of RKIP did not statistically associate with metastasis development either when including the whole spectrum of melanoma staging (q = 0.132), or if we only consider the clinical-risk subset of melanoma subjects (AJCC I + II) (q = 0.499) (Figure 1d).